Ignite Creation Date:
2024-05-06 @ 2:57 AM
Last Modification Date:
2024-10-26 @ 11:25 AM
Study NCT ID:
NCT02162966
Status:
UNKNOWN
Last Update Posted:
2015-04-01
First Post:
2014-05-21
Brief Title:
Safety and Efficacy Study of High Dose Colistin
Sponsor:
King Saud Medical City
Organization:
King Saud Medical City
Study Overview
Official Title:
Use Of High Dose Colistin in Multi Drug Resistant Gram Negative Infections in Critically Ill Adult Patients Randomized Controlled Clinical Trial
Status:
UNKNOWN
Status Verified Date:
2015-03
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Colistin is a rapidly acting bactericidal antimicrobial agent that possesses a post antibiotic effect against MDRO Gram-negative bacteria such as as Pseudomonas aeruginosa Acinetobacterbaumannii and Klebsiella pneumonia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None